We are pleased to announce that JETA Molecular will present the lecture titled “Application of dPCR for Monitoring Transplant Success” at the QIAGEN dPCR Used Day 2024, scheduled for August 29th in Breda. This presentation will address the utilization of DigitalTRACE™ assays in post-transplant monitoring. The subsequent talk, presented by Dr. Karin Boer from Erasmus MC in Rotterdam, will concentrate on the sensitive detection of cell-free donor-derived DNA following solid organ transplantation using the HoloGRAFT™ kit. We cordially invite you to attend this event.

The new HLA LOH monitoring assay targets HLA-A*03 and is available both for qPCR and for dPCR.

Following the successful EFI 2024 event in Geneva from 20-23 May, JETA Molecular has attended the American Transplant Congress in Philadelphia (June 1-5). We look forward to welcoming you at our booth during the SFHI Congress in Strasbourg from 9-11 October.

Should you require further information about our products for transplant monitoring, or if you would like to discuss our sensitive detection techniques and simple workflows with our experts, please do not hesitate to contact us!

Our software, developed for the chimerism monitoring after hematopoietic stem-cell transplantation, is now also supporting the new QX600 Droplet Digital PCR System. This new instrument from Biorad enables accurate quantification in combination with advanced six-color (FAM, HEX, Cy5, Cy5.5, ROX, and ATTO 590) multiplexing.

This year, JETA Molecular has for the first time set up a booth at the BSHI Conference 2023 held in Birmingham, UK on September 12-13. We will also be attending the SFHI 2023 meeting (October 11-13 in Reims, France - represented by our business partner Bionobis) and the ASHI 49th Annual Meeting on October 16-20 in San Antonio, Texas.

Please feel welcome to visit our booth and have a chat with us - not only about our increasingly popular DigitalTRACE™ kits!